Bayer CropScience Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|
| Revenue | 1,761.30 | 1,658.70 | 821.10 |
| Operating Expense | 1,553.80 | 1,317.20 | 694.90 |
| Net Profit | 136.30 | 254.20 | 96 |
| Net Profit Margin | 7.74 | 15.33 | 11.69 |
| Earning Per Share | 30.33 | 56.56 | 21.36 |
| EBIDTA | 207.70 | 340.30 | 128.10 |
| Effective Tax Rate | 26.02 | 17.69 | 8.95 |
| Particulars | Sep 2024 |
|---|---|
| Revenue | 1761.30 |
| Operating Expense | 1553.80 |
| Net Profit | 136.30 |
| Net Profit Margin | 7.74 |
| Earning Per Share | 30.33 |
| EBIDTA | 207.70 |
| Effective Tax Rate | 26.02 |
Invest in Bayer CropScience Ltd
₹0 Brokerage*
Open Demat Account
*By signing up you agree to our Terms and Conditions
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Total Revenue Annual | 5,103.20 | 5,139.70 | 4,734.40 |
| Operating Expenses Annual | 4,149.20 | 4,215.50 | 3,923.30 |
| Operating Profit Annual | 1,035 | 1,091.90 | 924.20 |
| Interest Annual | 19.60 | 22.30 | 12.90 |
| Depreciation | 37.60 | 38.50 | 39.60 |
| Net Profit Annual | 740.50 | 758.20 | 645.30 |
| Tax Annual | 200.90 | 231.90 | 201.50 |
| Particulars | Mar 2024 |
|---|---|
| Total Revenue Annual | 5,103.20 |
| Operating Expenses Annual | 4,149.20 |
| Operating Profit Annual | 1,035 |
| Interest Annual | 19.60 |
| Depreciation | 37.60 |
| Net Profit Annual | 740.50 |
| Tax Annual | 200.90 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Cash Flow at the Beginning | 860.80 | 780.90 | 1,204.50 |
| Cash Flow from Operations | 951.60 | 609.30 | 215.50 |
| Cash Flow from Investing | 0.40 | 83.30 | 64.20 |
| Cash Flow from Financing | -656.30 | -613.20 | -703.30 |
| Cash Flow at the End | 1,156.50 | 860.30 | 780.90 |
| Particulars | Mar 2024 |
|---|---|
| Cash Flow at the Beginning | 860.80 |
| Cash Flow from Operations | 951.60 |
| Cash Flow from Investing | 0.40 |
| Cash Flow from Financing | -656.30 |
| Cash Flow at the End | 1,156.50 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| PBDIT Margin (%) | 20.28 | 19.22 | 19.52 |
| PBIT Margin (%) | 18.83 | 17.67 | 18.16 |
| PBT Margin (%) | 17.87 | 16.88 | 16.75 |
| Net PROFIT Margin (%) | 14.51 | 14.75 | 13.63 |
| Return On Networth / Equity (%) | 26.63 | 25.91 | 25.43 |
| Return On Networth /Employed (%) | 32.25 | 32.05 | 31.79 |
| Return On Assets (%) | 24.81 | 26.70 | 23.85 |
| Total Debt / Equity (X) | 0.02 | 0.03 | 0.02 |
| Asset Turnover Ratio (%) | 1.71 | 1.81 | 1.75 |
| Particulars | Mar 2024 |
|---|---|
| PBDIT Margin (%) | 20.28 |
| PBIT Margin (%) | 18.83 |
| PBT Margin (%) | 17.87 |
| Net PROFIT Margin (%) | 14.51 |
| Return On Networth / Equity (%) | 26.63 |
| Return On Networth /Employed (%) | 32.25 |
| Return On Assets (%) | 24.81 |
| Total Debt / Equity (X) | 0.02 |
| Asset Turnover Ratio (%) | 1.71 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Fixed Assets Annual | 501.60 | 543.10 | 526.40 |
| Total Current Assets Annual | 3,905.50 | 3,896.40 | 3,575.50 |
| Non Current Assets Annual | 691.60 | 782.20 | 777.40 |
| Total Shareholders Funds Annual | 2,849.40 | 2,712.10 | 2,524.30 |
| Total Assets Annual | 4,597.10 | 4,678.60 | 4,352.90 |
| Particulars | Mar 2024 |
|---|---|
| Fixed Assets Annual | 501.60 |
| Total Current Assets Annual | 3,905.50 |
| Non Current Assets Annual | 691.60 |
| Total Shareholders Funds Annual | 2,849.40 |
| Total Assets Annual | 4,597.10 |
No Data Availabe
